We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
-23.9%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$302M
AUM Growth
-$151M
Cap. Flow
-$16.4M
Cap. Flow %
-5.44%
Top 10 Hldgs %
49.77%
Holding
317
New
38
Increased
51
Reduced
65
Closed
64

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$3.72M
2
SHOP icon
Shopify
SHOP
+$3.18M
3
ADSK icon
Autodesk
ADSK
+$3.15M
4
CRM icon
Salesforce
CRM
+$2.94M
5
HTZWW
Hertz Global Holdings Warrants
HTZWW
+$2.55M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$9.48M
2
ARGX icon
argenx
ARGX
+$4.12M
3
SE icon
Sea Limited
SE
+$3.9M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.16M
5
CHRD icon
Chord Energy
CHRD
+$3.12M

Sector Composition

Rank Sector Weight
1 Technology 27.72%
2 Healthcare 26.86%
3 Miscellaneous 22.85%
4 Communication Services 13.94%
5 Consumer Discretionary 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
276
Mastercard
MA
$521B
– –
-6,924
Closed -$2.47M
MA icon
277
PUT
Mastercard
MA
$521B
– –
-130
Closed -$287K
MVST icon
278
Microvast
MVST
$278M
– –
-43,653
Closed -$292K
NOMD icon
279
Nomad Foods
NOMD
$1.66B
– –
-9,407
Closed -$212K
NVTS icon
280
Navitas Semiconductor
NVTS
$3B
– –
-10,000
Closed -$103K
QSIAW
281
DELISTED
Quantum-Si Inc Warrant
QSIAW
– –
-100,414
Closed -$115K
RPRX icon
282
Royalty Pharma
RPRX
$27.1B
– –
-243,322
Closed -$9.48M
SLB icon
283
SLB Ltd
SLB
$85.1B
– –
-5,918
Closed -$244K
SNPS icon
284
Synopsys
SNPS
$84.8B
– –
-4,900
Closed -$1.63M
SPY icon
285
State Street SPDR S&P 500 ETF Trust
SPY
$825B
– –
-6,182
Closed -$2.79M
SST icon
286
PUT
System1
SST
$16.5M
– –
-49
Closed -$634K
VIR icon
287
Vir Biotechnology
VIR
$1.83B
– –
-24,000
Closed -$617K
DJT icon
288
PUT
Trump Media & Technology Group
DJT
$2.68B
– –
-59
Closed -$897K
OUSTZ
289
DELISTED
Ouster Inc Warrants
OUSTZ
– –
-47,567
Closed -$40K
ONC
290
BeOne Medicines Ltd
ONC
$41.5B
– –
-15,000
Closed -$2.83M
TE.WS
291
DELISTED
T1 Energy Inc Warrants
TE.WS
– –
-175,172
Closed -$739K
FFAI
292
Faraday Future Intelligent Electric
FFAI
$8.52M
– –
0
– -$236K
DNA.WS
293
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
– –
-195,263
Closed -$172K
VIEWW
294
DELISTED
View, Inc. Warrant
VIEWW
– –
-21,900
Closed -$6K
HLGN
295
DELISTED
Heliogen, Inc.
HLGN
– –
-809
Closed -$105K
ZEV
296
DELISTED
Lightning eMotors, Inc.
ZEV
– –
-1,769
Closed -$202K
IRNT
297
DELISTED
IronNet, Inc.
IRNT
– –
-101,832
Closed -$387K
EMBKW
298
DELISTED
Embark Technology, Inc. Warrants
EMBKW
– –
-18,421
Closed -$21K
CYXT
299
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
– –
-12,472
Closed -$152K
VORB
300
PUT
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
– –
-200
Closed -$269K
9 10 11
12
13

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, Privium Fund Management held 317 positions worth $302M, down 33% from $452M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Privium Fund Management withdrew a net $16.4M in Q2 2022, closing 64 positions and reducing 65 holdings. Its most notable exit was Royalty Pharma, an estimated $9.48M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Privium Fund Management opened a new position in Microsoft worth $2.06M.

  • Privium Fund Management's largest Q2 2022 buy was Microsoft: 8,000 shares worth $2.06M.
  • Privium Fund Management added most to Snowflake in Q2 2022, an estimated $3.72M increase.
  • Privium Fund Management's biggest Q2 2022 reduction was argenx, cutting an estimated $4.12M.
  • Privium Fund Management fully exited Royalty Pharma in Q2 2022, selling an estimated $9.48M.
  • Privium Fund Management's ten largest holdings make up 50% of its $302M portfolio in Q2 2022.
  • Privium Fund Management opened 38 new positions and closed 64 in Q2 2022.
  • Privium Fund Management's portfolio value fell 33% quarter-over-quarter to $302M.

Based on Privium Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.